Tags: spms + canada.with.MS

Sort by: Date / Title / URL

1. BioMS shares drop 90 percent on disappointing MS result
   Shares of BioMS Medical Corp (MS.TO: Quote) plunged 90 percent on Tuesday after the company and Eli Lilly and Co (LLY.N: Quote) said their multiple sclerosis treatment failed to delay the progression of the disease in a late-stage trial.
   29-07-2009 to canada, clinical trial, ms, multiple sclerosis, research, spms by admin
2. BioMS Medical Announces Lead Investigator In United States Phase III Multiple Sclerosis Trial
   BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), is pleased to announce Dr. Clyde E. Markowitz as the lead investigator in the United States for the Company’s pivotal phase III clinical trial of its lead dru
   28-04-2007 to canada, drug company, drugs, mbp8298, multiple sclerosis, spms by admin
3. BioMS Medical Announces Second Quarter 2006 Results
   More than 300 patients enrolled in pivotal phase II/III multiple sclerosis trial
   14-08-2006 to canada, clinical trial, drug company, drugs, multiple sclerosis, spms by admin
4. The Edward Bronfman Family Foundation Research Clinic in Secondary Progressive Multiple Sclerosis at Mount Sinai Hospital, Toronto, Canada
   The Edward Bronfman Family Foundation Research Clinic in Secondary Progressive Multiple Sclerosis is dedicated to researching alternative forms of therapy to alleviate the pain associated with Secondary Progressive Multiple Sclerosis (SPMS) and is associa
   30-06-2006 to canada, charity, multiple sclerosis, pain, spms by admin

First / Previous / Next / Last / Page 1 of 1